Literature DB >> 29844595

BACE failures lower AD expectations, again.

Asher Mullard.   

Abstract

Entities:  

Year:  2018        PMID： 29844595     DOI： 10.1038/nrd.2018.94

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

Review 1.  The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.

Authors:  Elizabeth R Sharlow; Mehmet Murat Koseoglu; George S Bloom; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2019-05-16       Impact factor: 1.738

2.  Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?

Authors:  Saak Victor Ovsepian; Valerie Bríd O'Leary
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

3.  New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties.

Authors:  Martín Estrada-Valencia; Clara Herrera-Arozamena; Concepción Pérez; Dolores Viña; José A Morales-García; Ana Pérez-Castillo; Eva Ramos; Alejandro Romero; Erik Laurini; Sabrina Pricl; María Isabel Rodríguez-Franco
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 4.  Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer's Disease.

Authors:  Zackary A Cope; Takeshi Murai; Stacey J Sukoff Rizzo
Journal:  Front Aging Neurosci       Date:  2022-02-17       Impact factor: 5.750

5.  Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration.

Authors:  Ryan T Vest; Ching-Chieh Chou; Hui Zhang; Michael S Haney; Lulin Li; Nouf N Laqtom; Betty Chang; Steven Shuken; Andy Nguyen; Lakshmi Yerra; Andrew C Yang; Carol Green; Mary Tanga; Monther Abu-Remaileh; Michael C Bassik; Judith Frydman; Jian Luo; Tony Wyss-Coray
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-08       Impact factor: 12.779

Review 6.  Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.

Authors:  Priscila Baltazar Gonçalves; Ana Carolina Rennó Sodero; Yraima Cordeiro
Journal:  Biomolecules       Date:  2021-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.